CD44 and cancer: identified CD44 as a cancer stem cell marker for HNSCC, finding significant increases in CD44 levels and associations with tumorigenesis, radiation resistance, CT resistance, and an increased immunosuppressive phenotype of HNSCC.83, 84, 85